Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. - Wikidata - awgldk - TriplyDB

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.

http://www.wikidata.org/entity/Q43049804

about

Receptor for advanced glycation end products and its involvement in inflammatory diseases Targeting HMGB1 in inflammation Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice Alarmins: awaiting a clinical response Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis.Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging Anti-RAGE antibody ameliorates severe thermal injury in rats through regulating cellular immune function.High-mobility group protein box-1 and its relevance to cerebral ischemia Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma.Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis.The effect of bortezomib on expression of inflammatory cytokines and survival in a murine sepsis model induced by cecal ligation and puncture.Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice Receptor for Advanced Glycation End Products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia.Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.HMGB1 is a therapeutic target for sterile inflammation and infection.sRAGE in diabetic and non-diabetic critically ill patients: effects of intensive insulin therapy RAGE Deficiency Impairs Bacterial Clearance in Murine Staphylococcal Sepsis, but Has No Significant Impact on Staphylococcal Septic Arthritis Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction Identification of haplotype tag single nucleotide polymorphisms within the receptor for advanced glycation end products gene and their clinical relevance in patients with major trauma.RAGE: exacting a toll on the host in response to polymicrobial sepsis and Listeria monocytogenes.High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease The receptor RAGE: Bridging inflammation and cancer Sepsis: links between pathogen sensing and organ damage Senescence-dependent impact of anti-RAGE antibody on endotoxemic liver failure Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury.AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis.Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation The role of receptor for advanced glycation endproducts (RAGE) in infection.Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis.Immunomodulatory therapy for sepsis: an update.Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.Cardiovascular disease and high-mobility group box 1--is a new inflammatory killer in town?Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis.

P2860

Q21285070-614E947B-6B5A-4835-8EF1-834A3A5A8A69 Q28266138-7BDAFC77-374E-4697-A28A-AB592D880B02 Q30410928-6D9F1C64-DE5E-4DA7-B4FF-56C6442B6C6B Q30484598-D90864C8-C020-4606-A022-9464AF6041FD Q30523797-85C9E673-8A09-4C79-BF8C-301CBA5D67A5 Q33709127-39C16A7F-57F2-4D02-AF95-9CA78CE590E8 Q33822512-2B4E5413-ABAE-44FE-8F17-DC31D50C85AE Q33940421-93C5F5C8-A839-4625-A490-F42FDE6C5FCA Q34067128-A8C15E94-9C6B-4879-B923-5739008A9071 Q34094369-AC436FD3-3ABA-4A5B-A740-0DE5D1DE4CF9 Q34138346-BD7F9BE7-1896-487C-A2B9-A32C964FBD78 Q34170847-FABC0056-8D5F-4754-AC46-902859D11161 Q34479261-50ED9EF7-3CD4-4DA2-9197-1A016E77080D Q34766912-735054C2-369A-4736-943C-6E9C84335FD2 Q34774088-14B05165-F4F8-49CC-827D-F4C4A1D45431 Q35188008-50E56A79-EEAC-4BE4-921F-1B2F7177BF56 Q35908548-60D3FED1-1B67-4141-A524-A854AC7EABAB Q35944988-30CCB8E8-9C5A-4E5C-B7B9-5D25DEC7D43B Q35953553-DC3702AD-E213-44BF-AE3D-9610429F19BD Q36070548-840F548E-6C1E-4E33-BDC5-886204E7D714 Q36209840-A4E09A08-6B5C-4C9A-B434-F73FE0B9EF13 Q36375004-4BDEEBB5-6A3C-4F9A-955E-F2AD4A4B099C Q36633916-D08AF807-4E61-452A-A05B-502F4A9C2BD0 Q37055335-CCE84B2E-E494-434E-9FC5-7D96E90DC606 Q37206315-F3836117-EA5F-4A1F-A0A8-19FF6D765067 Q37212720-EC960290-B3DF-44D4-B1B6-D94E69DCDF04 Q37239817-C450AED3-A6E5-44FA-AE45-24A71DE91622 Q37300540-148C83EE-86D0-4B00-8DC8-5C2615DF50C1 Q37316463-F8538945-A74B-4042-8B88-ECE88CE05332 Q37326771-6DBDCB5B-E2A2-4688-B551-AE1126F109B5 Q37384331-5AD3553F-B869-40D1-8F36-795C0E3ED32B Q37424029-8464B772-ADFC-465B-B2C7-D1D16995F854 Q37860412-966A5CE8-14A4-4406-81B3-0D91CC23D2D8 Q37879190-98D11C31-D0A6-4D5F-B4BA-87F7C8CB7768 Q37949639-9D921AA5-CC35-4390-A89B-C8031F5E2943 Q37972674-3BFE8CF2-1E6E-40A0-B093-74C13BD2058F Q38040046-73893D20-62A8-49A5-9326-175B493DE2BA Q38756562-D91AECD4-2B2F-4070-8C4D-BCFF8DE0CF1C Q38939435-7F89B06D-E0EF-4F43-886D-7D3CD290EF25 Q39094081-7163FCFA-EA1D-4A22-8A36-9F876B86066C

P2860

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.

http://www.wikidata.org/entity/Q43049804

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Inhibition of the RAGE product ...... sepsis and systemic infection.

@en

Inhibition of the RAGE product ...... sepsis and systemic infection.

@nl

type

label

Inhibition of the RAGE product ...... sepsis and systemic infection.

@en

Inhibition of the RAGE product ...... sepsis and systemic infection.

@nl

prefLabel

Inhibition of the RAGE product ...... sepsis and systemic infection.

@en

Inhibition of the RAGE product ...... sepsis and systemic infection.

@nl

P1433

Q43049804-DA819054-F89D-47AA-8F16-573047B935F1

P1476

Q43049804-56EBD713-6D72-4C6A-81CF-D4C7F51AC81B

P2093

Q43049804-22E95B56-6E5E-4C3B-BFBA-AC8B9F23F21A

Q43049804-2DBA16F2-2DBA-4EAA-A53A-8FCC6BE3F8FC

Q43049804-2FD854E5-0935-4B29-A7F7-8EB43AF8E372

Q43049804-3A481DC7-7336-4936-9330-58FC87DB1693

Q43049804-47E9789E-F136-4610-A36D-32D9D00A8404

Q43049804-52331DF8-C920-4980-B294-EF0E85110E57

Q43049804-6B1786BB-953A-4BFF-A21D-4EE71B7FF651

Q43049804-6F07B63F-ECCC-4ABF-A136-C64E42D099E0

Q43049804-862583D5-963D-4C26-9481-6F1B1634B1D2

Q43049804-A6A55344-8A37-4E13-951A-DF062EA7A7A5

P2860

Q43049804-00C0D9D3-351B-454F-8AD8-EBD1C5B375F8

Q43049804-1EB3F55D-C9DF-49D3-97C4-7918296BCB83

Q43049804-2F136A66-F9B1-4A7A-9788-AAE1F1410522

Q43049804-364E627B-EABC-474A-9A88-20C1B36E2294

Q43049804-4F863D53-B7A8-449E-8087-30A65A6DE188

Q43049804-53047818-5E7E-43FE-A703-D4203AE89E80

Q43049804-646A9329-F9D6-46D8-946B-19A66666961A

Q43049804-6477D253-5939-42E3-8DF4-2BE60E719525

Q43049804-6E97A16D-F10F-492C-A75C-5D27EE8D61EA

Q43049804-744D383F-4B18-4100-B639-8210C9FCFB84

P2888

Q43049804-B20C5F1A-79B6-400D-B1D8-93A89CC3F62C

P304

Q43049804-380B1C29-1ECD-45D7-8F29-A99CD715EA48

P31

Q43049804-DC606D41-B968-40D7-BF6A-A9F7BA38696E

P356

Q43049804-E405DC51-3843-4461-84F1-A641B1DD3755

P433

Q43049804-79155203-4A51-4749-AF53-7E57CAE8C519

P478

Q43049804-34C22DC0-567F-4219-8C21-F167EFEDB5BC

P577

Q43049804-89D3967A-AB24-4CE2-A5C6-906188732423

P5875

Q43049804-1A3B8E56-9EBD-408C-B7F8-9C7BD45A7CE8

P698

Q43049804-3913F0FC-CAA7-4354-955D-95CC9B07D439

P921

Q43049804-4F62362C-7A3F-4AC3-AE44-14C48694FF92

P932

Q43049804-A68260D4-A20C-4A40-B40E-3108EEEC2AEE

P356

P1433

P1476

Inhibition of the RAGE product ...... sepsis and systemic infection.

@en

P2093

Brian M Clancy

http://www.w3.org/2001/XMLSchema#string

Debra D Pittman

http://www.w3.org/2001/XMLSchema#string

Emily C Lutterloh

http://www.w3.org/2001/XMLSchema#string

Helen Palmer

http://www.w3.org/2001/XMLSchema#string

James C Keith

http://www.w3.org/2001/XMLSchema#string

John E Palardy

http://www.w3.org/2001/XMLSchema#string

Kim Milarski

http://www.w3.org/2001/XMLSchema#string

Nicholas A Parejo

http://www.w3.org/2001/XMLSchema#string

Noubar Kessimian

http://www.w3.org/2001/XMLSchema#string

Steven M Opal

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

The biology of the receptor for advanced glycation end products and its ligands.

Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Listeria monocytogenes: clinical and experimental update.

RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease.

P2888

P304

R122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC6184

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5806157

http://www.w3.org/2001/XMLSchema#string

P698

18042296

http://www.w3.org/2001/XMLSchema#string

P921

P932

2246216

http://www.w3.org/2001/XMLSchema#string